Clinical Trials
25 trialsNCT02755844 2026-05-27
ENDOLA
Hospices Civils de Lyon
Phase 1/2 Completed
NCT06010160 2026-05-27
GC-CCP
RAND
Phase NA Completed
NCT06102252 2026-05-22
Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as Aneo Adjuvant Treatment in Advanced Endometrial Carcinoma
Sohag University
Phase NA Completed
NCT03430700 2026-05-20
PROMPT
University College, London
Phase 2 Completed
NCT04008095 2026-05-20
COLTEP
University Hospital, Brest
Completed
NCT03180294 2026-05-19
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
NRG Oncology
Phase 2 Completed
NCT07017387 2026-05-19
Impact of Education Methods on HPV Knowledge and Screening Behavior
Saglik Bilimleri Universitesi Gulhane Tip Fakultesi
Phase NA Completed
NCT00040222 2026-05-18
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
National Institutes of Health Clinical Center (CC)
Completed
NCT06519994 2026-05-14
Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya
UNC Lineberger Comprehensive Cancer Center
Phase 2 Completed
NCT04214210 2026-05-13
DIALOGUE
University of Basel
Phase NA Completed
NCT04295577 2026-05-13
MONITOR-UK
Royal Marsden NHS Foundation Trust
Completed
NCT06464107 2026-05-13
Endometrial Cell Collection With the PadKit
Hackensack Meridian Health
Phase NA Completed
NCT03726151 2026-05-12
Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs
University of California, Los Angeles
Phase NA Completed
NCT04354246 2026-05-12
COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies
Compugen Ltd
Phase 1 Completed
NCT04902872 2026-05-12
Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors
Cybrexa Therapeutics
Phase 1/2 Completed
NCT00959647 2026-05-08
A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study
Genentech, Inc.
Phase 2 Completed
NCT03603808 2026-05-08
VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions
AIDS Malignancy Consortium
Phase 2 Completed
NCT00043472 2026-05-07
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
National Institutes of Health Clinical Center (CC)
Completed
NCT00086567 2026-05-07
Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers
National Institutes of Health Clinical Center (CC)
Completed
NCT03979014 2026-05-06
NOVEL
Imperial College London
Phase 3 Completed
NCT04726319 2026-05-06
FHAMe
University of Toronto
Phase NA Completed
NCT06576908 2026-05-06
Evaluation of On-Couch CBCT Image Quality
Varian, a Siemens Healthineers Company
Phase NA Completed
NCT07567573 2026-05-05
retroESGO ov1
European Society of Gynaecological Oncology
Completed
NCT03740165 2026-05-04
KEYLYNK-001
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT03797326 2026-05-04
LEAP-005
Merck Sharp & Dohme LLC
Phase 2 Completed